SpartanDONews

College News

Category:
Group:
Search:
MSU presents "Slavery To Freedom" lecture series with speaker Patrisse Cullors
Today (Feb. 11), the Michigan State University College of Osteopathic Medicine continues its 2021 Dr. William G. Anderson Lecture Series, “Slavery To Freedom.” Due to COVID-19,…
Category:
  • Diversity, Inclusion and Safety
Group:
  • Students,
  • Faculty/Staff,
  • Alumni
Read More
Innovation, bonuses may help curb Michigan’s home health care shortage
Like home care agencies across the country, New York City’s Cooperative Home Care Associates faced a nagging challenge: How to hire and retain quality direct care workers?
Category:
  • #SpartanDO In the News,
  • Research and Scholarly Activity
Group:
  • Students,
  • Faculty/Staff,
  • Alumni
Read More
As Michigan ages, a shortage in health care workers explodes into a crisis
Living alone in a Grand Rapids apartment, 84-year-old Nancy Klomparens clings to her independence — and has the injuries to show for it. Poor eyesight contributed to a series of…
Category:
  • #SpartanDO In the News,
  • Research and Scholarly Activity
Group:
  • Students,
  • Faculty/Staff,
  • Alumni
Read More
Can you take tylenol or ibuprofen before or after you get the COVID-19 vaccine?
COVID-19 vaccine distribution is underway in the U.S., but there’s a lot more work to be done, according to data from the Centers for Disease Control and Prevention (CDC). While…
Category:
  • #SpartanDO In the News,
  • Research and Scholarly Activity
Group:
  • Students,
  • Faculty/Staff,
  • Alumni
Read More
Coronavirus FAQ: I'm using a UV light to disinfect stuff. Is that a good idea?
I'm using a lamp that emits UV light in my house to try and kill pathogens — the coronavirus in particular. Is it doing any good? And ... could exposure to the light be risky for…
Category:
  • #SpartanDO In the News,
  • Research and Scholarly Activity
Group:
  • Students,
  • Faculty/Staff,
  • Alumni
Read More
Mid-Michigan expert explains benefits and challenges of new Johnson & Johnson COVID vaccine
On Friday, Johnson & Johnson released the phase three global trial results for their one-shot COVID-19 vaccine. The trial was conducted with 44,000 participants over the age of 18.
Category:
  • #SpartanDO In the News,
  • Research and Scholarly Activity
Group:
  • Students,
  • Faculty/Staff,
  • Alumni
Read More